Patients with early-stage bladder cancer are often able to maintain their usual routines. Some may experience urinary ...

Although bladder cancer ranks as the sixth most common cancer in the United States, with approximately 85,000 new cases diagnosed each year, it continues to receive limited awareness, advocacy, and ...

For people with non–muscle invasive bladder cancer (NMIBC), the reality can be especially pronounced. The disease is often persistent, requiring repeated treatments, frequent monitoring, and ongoing ...

The VOLGA trial was the first to combine two immune checkpoint inhibitors with a targeted therapy in the perioperative ...

SURGERY to remove the bladder of cancer patients could be avoided in thousands of cases thanks to a new drug combination.

NMIBC treatment varies by tumor stage, grade, and prior therapies, with high-risk cases often requiring radical cystectomy. Bladder-preserving approaches include intravesical therapies like BCG, ...

A promising new drug is raising hopes for bladder cancer patients by potentially reducing the need for life-changing surgery.

A breakthrough in bladder cancer treatment is helping save more lives. The American Cancer Society estimates that 83,000 new cases of bladder cancer will be diagnosed this year. 17,000 will die from ...

A groundbreaking targeted treatment for the most common type of bladder cancer has been approved for use by the NHS, offering new hope to hundreds of patients. The National Institute of Health and ...

When bladder cancer metastasizes, it can cause pain in the areas it spreads to — mainly the lymph nodes, pelvis, lungs, liver, and bones. The severity of the pain can vary, too, depending on how ...

More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first immunotherapy against cancer. And it is still used today to treat ...

The presence of blood cells in urine is a sign of bladder cancer. Because aspirin blocks platelets from forming harmful blood ...